The facts are sourced from a DEFM14A filed with the SEC via EDGAR, published on February 4, 2026. A DEFM14A is a definitive merger proxy statement, consistent with the plan-of-arrangement structure requiring shareholder approval. The deal's current status is pending regulatory review.
Two financial advisors are identified on the target side, each having rendered a fairness opinion. Evans & Evans, Inc. provided a fairness opinion, as referenced by the source sentence "ANNEX D OPINION OF EVANS & EVANS, INC." Truist Securities, Inc. served as the lead financial advisor and also provided a fairness opinion, per the source sentence "ANNEX C OPINION OF TRUIST SECURITIES, INC." No financial advisor to REM Aggregator LLC, the acquirer, is identified in the facts provided.
Only one legal advisor is identified in the facts block: DLA Piper (Canada) LLP, representing the target side, Quipt Home Medical Corp. The source sentence notes that "a copy of the Arrangement Agreement will also be available for inspection at the offices of DLA Piper (Canada) LLP, Suite 2700, 1133 Melville Street Vancouver, BC V6E 4E5 Canada during statutory business hours," indicating DLA Piper's role in connection with the arrangement agreement.
Beyond the classification of this transaction as a cash acquisition via plan of arrangement, no further detail on the per-share cash consideration or other specific terms is included in the facts provided.
Several items are not disclosed in this record: the transaction value is not stated, the per-share cash consideration is not specified, no financial or legal advisor to REM Aggregator LLC is identified, and no expected closing date is given beyond the pending-regulatory status.